Selective serotonin reuptake inhibitors use in pregnancy: a risk assessment study using administrative pharmaceutical data
Background Antidepressant management with Selective Serotonin Reuptake Inhibitors (SSRI) during pregnancy is associated with risks of congenital malformations and adverse pregnancy outcomes. Main Aim We examined the incidence of SSRI use during pregnancy using Australian administrative pharmaceu...
Main Authors: | Shaun Purkiss, Tessa Keegel, Hassan Vally, Dennis Wollersheim |
---|---|
Format: | Article |
Language: | English |
Published: |
Swansea University
2019-11-01
|
Series: | International Journal of Population Data Science |
Online Access: | https://ijpds.org/article/view/1167 |
Similar Items
-
Incidence of drug-treated chronic diseases using administrative pharmaceutical data
by: Shaun Purkiss, et al.
Published: (2019-11-01) -
Estimates of mortality rates in people with diabetes and cardiovascular disease using administrative pharmaceutical data
by: Shaun Purkiss, et al.
Published: (2019-11-01) -
Estimates of age-specific death rates and mortality risk using administrative pharmaceutical data
by: Shaun Purkiss, et al.
Published: (2019-11-01) -
Estimates of drug treated diabetes incidence and prevalence using Australian administrative pharmaceutical data
by: Shaun Francis Purkiss, et al.
Published: (2021-05-01) -
Estimates of age specific death rates in people with diabetes and associated multimorbidity using Australian administrative pharmaceutical data
by: Shaun Francis Purkiss, et al.
Published: (2021-03-01)